Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances

Details for Australian Patent Application No. 2004233572 (hide)

Owner Schering Aktiengesellschaft

Inventors Franke, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2004233572

PCT Pub. Number WO2004/096191

Priority 03008856.1 28.04.03 EP

Filing date 21 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 15 July 2010

International Classifications

A61K 31/265 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096191 Priority application(s): WO2004/096191

15 July 2010 Application Accepted

  Published as AU-B-2004233572

5 August 2010 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233575-9-azabicyclo'3.3.1!non-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors

2004233571-Imidazolin-2-ylaminophenyl amides as IP antagonists